SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Alimera Sciences (ALIM)

ALIM RSS Feed
Add ALIM Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board:
Last Post: 1/20/2017 3:43:58 AM - Followers: 37 - Board type: Free - Posts Today: 0




Alimera Sciences, Inc. (Alimera) is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals.
The Company focuses on diseases affecting the back of the eye, or retina. The Company's commercial product is ILUVIEN, which has been developed to
treat diabetic macular edema (DME). ILUVIEN has received marketing authorization in the United States, Austria, Belgium, the Czech Republic, Denmark,
Finland, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden and the United Kingdom.
In the United States, ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and
did not have a rise in intraocular pressure (IOP). In the EU countries, it is indicated for the treatment of vision impairment associated with DME.


ALIM http://seekingalpha.com/article/3967057-2-small-biotech-stocks-poised-substantial-upside ;

https://www.google.com/finance?q=alim&ei=i_AYV-CbFsrHigKv8oioDA


Fox Business News interview with the CEO accounted for the news. 
04-21-2016
http://bit.ly/23LQSlZ 

FDA approves new diabetes implant 
Apr. 21, 2016 - 3:25 - Alimera Sciences CEO Dan Myers on a new diabetes implant that treats macular degeneration.
 http://www.alimerasciences.com/
http://www.alimerasciences.com/

Retinal Vein Occlusion (RVO)

ILUVIEN® Patent Notices

Please see the following table for U.S. Patents covering ILUVIEN®. The absence of a U.S. Patent number as associated with ILUVIEN does not constitute a waiver of our patent, trademark, or other intellectual property rights concerning that product.

PRODUCT

PATENT NO.

ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg

U.S. 6,217,895

U.S. 6,375,972

U.S. 6,548,078

U.S. 8,252,307

U.S. 8,574,659

U.S. 8,871,241

 
http://www.alimerasciences.com/wp-content/uploads/2016/02/Prescribing-Information.pdf

http://finance.yahoo.com/q/ks?s=ALIM+Key+Statistics

Alimera Sciences, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The company focuses on diseases affecting the back of the eye or retina. The company is developing ILUVIEN, an intravitreal insert in phase-3 clinical trials for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness. Its ILUVIEN insert designed to be inserted into the patient's eye to release a daily dose of fluocinolone acetonide over an anticipated period of 24 to 36 months. The company also conducts phase-2 clinical trials on ILUVIEN for the treatment of the dry form of age-related macular degeneration (AMD), the wet form of AMD, and retinal vein occlusion. In addition, it conducts testing on two classes of nicotinamide adenine dinucleotide phosphate oxidase inhibitors. Further, the company develops ILUVIEN inserter, a custom insertion system for ILUVIEN. Alimera Sciences, Inc. was founded in 2003 and is headquartered in Alpharetta, Georgia.
 
Alimera Sciences Inc. is based out of Alpharetta, GA and has some 132 employees.

Officers and directors

 
Richard S. Eiswirth Jr.   President, Chief Financial Officer
C. Daniel Myers   Chief Executive Officer, Director
Kenneth E Green Ph.D.   Senior Vice President, Chief Scientific Officer
David R Holland   Senior Vice President - Sales and Marketing
Philip Ashman   Senior Vice President, European Managing Director
David Burke   Vice President
Mark J. Brooks   Independent Director
Brian K. Halak Ph.D.   Independent Director
James R. Largent   Independent Director
Peter J. Pizzo III   Independent Director
 

Stonegate Capital Partners Initiates Coverage on Alimera Sciences

http://www.barchart.com/headlines/story/1467222/stonegate-capital-partners-initiates-coverage-on-alimera-sciences
ACCESSWIRE via CMTX - Wed Apr 27, 8:02AM CDT


 


Alimera Sciences Reports Record Fourth Quarter and Full Year 2015 Financial Results
Mar 2, 2016



 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ALIM
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ALIM News: Statement of Ownership (sc 13g) 01/19/2017 04:31:23 PM
ALIM News: Amended Statement of Ownership (sc 13g/a) 01/12/2017 04:43:41 PM
ALIM News: Securities Registration: Employee Benefit Plan (s-8) 01/06/2017 04:06:17 PM
ALIM News: Statement of Changes in Beneficial Ownership (4) 12/14/2016 04:32:02 PM
ALIM News: Statement of Ownership (sc 13g) 11/17/2016 02:49:55 PM
PostSubject
#779  Sticky Note good morning, news/ Alimera Sciences Begins Selling ILUVIEN® mick 10/26/16 10:22:02 AM
#827   .0001 CarlCarlMcB 01/20/17 03:43:58 AM
#826   Looking forward to next earnings report. Hopefully Norm 01/14/17 06:36:27 PM
#825   Yes, PPS target $4 end of year!! Backdraft4u 01/14/17 02:51:43 PM
#824   To the moon! UserBob 01/12/17 09:35:09 PM
#823   Why are up more than 12%. What happened?? pennies from heaven 01/10/17 11:40:10 AM
#822   http://www.otcmarkets.com/stock/ALIM mick 01/10/17 10:15:12 AM
#821   Timber CarlCarlMcB 01/10/17 09:32:22 AM
#820   Alimera Sciences, In (ALIM) mick 01/07/17 12:32:04 PM
#819   Okay !!! .25 ! CarlCarlMcB 01/07/17 12:21:22 PM
#818   Alimera Sciences, In (ALIM) mick 01/04/17 12:31:34 PM
#817   ALIM News: Statement of Changes in Beneficial Ownership mick 01/04/17 12:31:10 PM
#816   1.02 soon CarlCarlMcB 01/04/17 11:43:53 AM
#815   Falling knife! CarlCarlMcB 01/04/17 08:33:17 AM
#814   Why are you so vested in AlIMs failure? UserBob 01/04/17 08:30:09 AM
#813   Tic tock ! .01 CarlCarlMcB 01/04/17 07:51:32 AM
#812   Alimera Sciences, In (ALIM) mick 01/03/17 09:35:04 PM
#811   Grab a parachute!!! ! Free fall CarlCarlMcB 01/03/17 08:22:23 PM
#810   Alimera Sciences, In (ALIM) mick 01/03/17 01:07:31 PM
#809   .01 CarlCarlMcB 01/03/17 11:29:04 AM
#808   Alimera Sciences, In (ALIM) mick 12/31/16 07:20:00 PM
#807   ALIM News: Statement of Changes in Beneficial Ownership mick 12/31/16 07:19:47 PM
#806   Rolling over CarlCarlMcB 12/22/16 01:13:43 PM
#805   Timber .01 CarlCarlMcB 12/21/16 03:02:03 PM
#804   ALIM News: Statement of Changes in Beneficial Ownership mick 12/21/16 10:21:55 AM
#803   Alimera Sciences, In (ALIM) mick 12/21/16 10:21:46 AM
#802   Shorts moving in. CarlCarlMcB 12/21/16 10:01:30 AM
#801   .25 CarlCarlMcB 12/21/16 09:56:12 AM
#800   Alimera Sciences, In (ALIM) mick 12/20/16 01:14:56 PM
#799   Timber !!!$$$$ .25 CarlCarlMcB 12/20/16 12:07:43 PM
#798   great volume/ https://www.barchart.com/stocks/quotes/ALIM/opinion mick 12/12/16 10:48:18 PM
#797   Whale forming! .25 ! CarlCarlMcB 12/12/16 04:40:08 PM
#796   [-chart]ih.advfn.com/p.php?pid=staticchart&s=alim&p=0&t=17&showctype=1&width=336 mick 12/12/16 02:07:47 AM
#795   Hard turn down! CarlCarlMcB 12/08/16 05:37:14 AM
#794   breathing again, Alimera Sciences, In (ALIM) mick 12/07/16 11:28:16 AM
#793   Alimera Sciences, In (ALIM) mick 12/07/16 12:44:32 AM
#792   ALIM News: Statement of Ownership (sc 13g) 11/17/2016 02:49:55 PM mick 12/07/16 12:44:19 AM
#791   Timber CarlCarlMcB 12/06/16 01:27:55 PM
#790   all pharma mostly debt/ urn rate highest between them. mick 11/30/16 09:47:05 AM
#789   Debt, CarlCarlMcB 11/30/16 09:40:07 AM
#788   i would like to see this company make mick 11/30/16 09:06:34 AM
#787   Timber CarlCarlMcB 11/30/16 05:29:27 AM
#786   Alimera Sciences, In (ALIM) mick 11/25/16 09:42:56 AM
#785   Timber .01 CarlCarlMcB 11/25/16 09:41:28 AM
#784   Alimera Sciences, In (ALIM) mick 11/10/16 12:23:33 PM
#783   What gives here? a quick look at the sub360 11/03/16 07:20:14 AM
#782   Alimera Sciences, In (ALIM) mick 10/29/16 05:42:40 PM
#781   ALIM News: Alimera Sciences Begins Selling ILUVIEN® in mick 10/29/16 05:42:27 PM
#780   Great news Go $ALIM $Pistol Pete$ 10/26/16 11:03:09 AM
#779   good morning, news/ Alimera Sciences Begins Selling ILUVIEN® mick 10/26/16 10:22:02 AM
#778   Timber! $$$ CarlCarlMcB 10/25/16 12:41:50 PM
PostSubject